Astrazeneca (AZN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Astrazeneca (AZN) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.04 Bn | 602.06 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.64 Bn | 362.64 Bn | - |
| 3 | General Electric | 329.87 Bn | 320.52 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.67 Bn | 248.39 Bn | 12.86 Bn |
| 5 | Citigroup | 228.64 Bn | -2,073.66 Bn | 24.75 Bn |
| 6 | Bhp | 216.08 Bn | 197.54 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - |
| 9 | Unilever | 139.34 Bn | 132.31 Bn | - |
| 10 | Hdfc Bank | 117.87 Bn | 80.72 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.44% |
| Mar 31, 2026 | 14.56% |
| Dec 31, 2025 | 20.15% |
| Sep 30, 2025 | 42.05% |
| Jun 30, 2025 | 29.33% |
| Mar 31, 2025 | 30.18% |
| Dec 31, 2024 | 23.74% |
| Sep 30, 2024 | 35.54% |
| Jun 30, 2024 | 71.47% |
| Mar 31, 2024 | 29.73% |
| Dec 31, 2023 | 29.57% |
| Sep 30, 2023 | 91.40% |
| Jun 30, 2023 | 38.14% |
| Mar 31, 2023 | 39.61% |
| Dec 31, 2022 | 53.70% |
| Sep 30, 2022 | 27.49% |
| Jun 30, 2022 | 10.05% |
| Mar 31, 2022 | -6.39% |
| Dec 31, 2021 | -24.82% |
| Sep 30, 2021 | 2.10% |